China Money Network
Login
Join

Chinese Clinical Stage Biotech Firm InventisBio Closes $70M Series C Round

  • March 12, 2019 — 11:02 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese clinical stage biotechnology company InventisBio Inc. announced on Monday the closing of a US$70 million series C round of financing led by Chinese private... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: